Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus

ClinicalTrials.gov ID: NCT00003128

Public ClinicalTrials.gov record NCT00003128. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Trial of Ifosfamide (NSC #109274) Versus Ifosfamide Plus Paclitaxel (NSC #125973) in Patients With Advanced, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus

Study identification

NCT ID
NCT00003128
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
166 participants

Conditions and interventions

Conditions

Interventions

  • filgrastim Biological
  • ifosfamide Drug
  • paclitaxel Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 1997
Primary completion
Jan 31, 2007
Completion
Not listed
Last update posted
Jul 8, 2013

Started 1997

United States locations

U.S. sites
17
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300
Stanford Cancer Center at Stanford University Medical Center Stanford California 94305-5216
CCOP - Carle Cancer Center Urbana Illinois 61801
Indiana University Cancer Center Indianapolis Indiana 46202-5289
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601
CCOP - Ochsner New Orleans Louisiana 70121
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231
Tufts - New England Medical Center Boston Massachusetts 02111
University of Minnesota Cancer Center Minneapolis Minnesota 55455
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106
Norris Cotton Cancer Center at Dartmouth Medical School Lebanon New Hampshire 03756-0002
MBCCOP-Our Lady of Mercy Cancer Center The Bronx New York 10466
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001
Abramson Cancer Center at University of Pennsylvania Medical Center Philadelphia Pennsylvania 19104
Fox Chase Cancer Center Philadelphia Pennsylvania 19111-2497
CCOP - Scott and White Hospital Temple Texas 76508

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003128, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003128 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →